enGene Therapeutics ENGN
NASDAQ ENGN
$2.41 +0.13 (+5.70%)
At close: Nov 13, 2026 · 4:00 PM EST

enGene Therapeutics (ENGN) Interest Paid (2023 - 2026)

Updated

Analysis

enGene Therapeutics (ENGN) Interest Paid (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -1.78 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 283.00 Mn
10 enGene Therapeutics 161.50 Mn -832.97 Mn - 590,000.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 590,000.00
Apr 30, 2026 456,000.00
Jan 31, 2026 544,000.00
Oct 31, 2025 711,000.00
Jul 31, 2025 532,000.00
Apr 30, 2025 514,000.00
Jan 31, 2025 532,000.00
Oct 31, 2024 532,000.00
Jul 31, 2024 526,000.00
Apr 30, 2024 584,000.00
Jan 31, 2024 283,000.00
Oct 31, 2023 457,000.00
Jul 31, 2023 265,000.00
API Access

enGene Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=ENGN&period=max&api_key=YOUR_API_KEY